Back
Verve Therapeutics Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
1
VERV
Verve Therapeutics
Last Price:
6.39
Seasonality Move:
-35.34%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VERV is experiencing slight selling pressure.
Verve Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.03 | Buy |
| 20-day SMA: | 5.62 | Buy |
| 50-day SMA: | 5.46 | Buy |
| 200-day SMA: | 7.67 | Sell |
| 8-day EMA: | 6.07 | Buy |
| 20-day EMA: | 5.75 | Buy |
| 50-day EMA: | 5.58 | Buy |
| 200-day EMA: | 7.66 | Sell |
Verve Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.27 | Buy |
| Relative Strength Index (14 RSI): | 68.75 | Buy |
| Chaikin Money Flow: | -617678 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.87 - 6.03) | Buy |
| Bollinger Bands (100): | (4.82 - 6.46) | Buy |
Verve Therapeutics Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Verve Therapeutics Stock
Is Verve Therapeutics Stock a Buy?
- Verve Therapeutics share price is 6.42 while VERV 8-day simple moving average is 6.03, which is a Buy signal.
- The stock price of VERV is 6.42 while Verve Therapeutics 20-day SMA is 5.62, which makes it a Buy.
- Verve Therapeutics 50-day simple moving average is 5.46 while VERV share price is 6.42, making it a Buy technically.
- VERV stock price is 6.42 and Verve Therapeutics 200-day simple moving average is 7.67, creating a Sell signal.
VERV Technical Analysis vs Fundamental Analysis
Sell
1
Verve Therapeutics (VERV)
is a Sell
Is Verve Therapeutics a Buy or a Sell?
-
Verve Therapeutics stock is rated a Sell
The current Verve Therapeutics [VERV] share price is $6.42. The Score for VERV is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
Verve Therapeutics Stock Info
Market Cap:
543.54M
Price in USD:
6.42
Share Volume:
1.31M
Verve Therapeutics 52-Week Range
52-Week High:
20.12
52-Week Low:
4.31
Sell
1
Verve Therapeutics (VERV)
is a Sell
Verve Therapeutics Share Price Forecast
-
What is the Verve Therapeutics stock price today?
The Verve Therapeutics stock price is 6.42 USD today. -
Will VERV stock go up or go down?
Verve Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Verve Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Verve Therapeutics is overvalued.
Is Verve Therapeutics Stock a Buy?
- Verve Therapeutics share price is 6.42 while VERV 8-day exponential moving average is 6.07, which is a Buy signal.
- The stock price of VERV is 6.42 while Verve Therapeutics 20-day EMA is 5.75, which makes it a Buy.
- Verve Therapeutics 50-day exponential moving average is 5.58 while VERV share price is 6.42, making it a Buy technically.
- VERV stock price is 6.42 and Verve Therapeutics 200-day simple moving average is 7.66, creating a Sell signal.
Fundamental Analysis of Verve Therapeutics
Is Verve Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.78 per share, and a decrease next year of $0.43 per share.
Technical Analysis of Verve Therapeutics
Should I short Verve Therapeutics stock?
- VERV Moving Average Covergence Divergence (MACD) indicator is 0.27, suggesting Verve Therapeutics is a Buy
- Verve Therapeutics Relative Strength Index (RSI) is 68.75, which suggest Verve Therapeutics is overbought
- The Bollinger Bands (25) for Verve Therapeutics is (4.87 - 6.03), which suggest Verve Therapeutics is a Buy
- The Bollinger Bands (100) for Verve Therapeutics is (4.82 - 6.46), which suggest Verve Therapeutics is a Buy
* Verve Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.